PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Shares Sold by Equitec Proprietary Markets LLC

Equitec Proprietary Markets LLC cut its holdings in shares of PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Free Report) by 81.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 61,415 shares of the company’s stock after selling 269,279 shares during the quarter. […]

Related Keywords

United States , ,Pharmacyte Biotech Company Profile ,Nasdaq ,Equitec Proprietary Markets ,Pharmacyte Biotech Inc ,Securities Exchange Commission ,Millennium Management ,Charles Schwab Investment Management Inc ,Acadian Asset Management ,Dimensional Fund Advisors ,Pharmacyte Biotech ,Free Report ,Cyte Biotech ,Proprietary Markets ,Asset Management ,Schwab Investment Management ,Street Group ,Visit Holdingschannel ,Pharmacyte Biotech Daily ,Nasdaq Pmcb ,Pmcb ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,